MedTrace Logo

Efficacy and Safety of Frequently Modified Intensive Insulin

NCT01014832 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2009-11-17

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy and safety of frequently modified intensive insulin therapy in patients with Type-2 and Type-1 diabetes mellitus.

Conditions

Interventions

DRUG

Intensive insulin therapy

Intensive insulin therapy

Sponsors & Collaborators

  • TKL Research, Inc.

    collaborator INDUSTRY

  • Hygieia, Inc

    lead INDUSTRY

Principal Investigators

  • Israel Hodish, MD. PhD. · Hygieia, Inc

  • Michael Casser, MD · TKL Research, Inc.

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
25 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2009-08-31
Completion
2009-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01014832 on ClinicalTrials.gov